BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that based on related clinical trials and studies of vaccination for local children and adolescents, the Health Bureau of the Government of the Hong Kong Special Administrative Region of the People’s Republic of China has approved … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, today released a statement regarding results of a jury trial in the patent litigation brought by Magnolia Medical Technologies. Magnolia Medical originally asserted four patents in the case. By the time of the trial, all of these patents were dropped, … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Neonatal Care Devices Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. The neonatal care industry is shifting its focus to providing family-centric and developmental care to neonates. Neonatal Intensive Care Units (NICUs) are looking at reducing neonatal stress, such as noise and intense light, to provide complete holistic care for neonates. … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Biotechnology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global biotechnology market reached a value of US$ 617.98 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 964.96 Billion by 2027, exhibiting a CAGR of … [Read more…]
At the primary analysis, the trial did not meet its primary endpoint of overall survival (OS) The safety profile was consistent with previously reported studies of Onivyde® (irinotecan liposomal injection) The clinical study results will be communicated with the regulatory agency PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Phase III … [Read more…]
Webcast Scheduled for Tomorrow, August 3, 2022, at 9:00 a.m. CT (10:00 a.m. ET) Revenues of $62.5 million increased 11% sequentially compared to third quarter this year and decreased 12% compared to fourth quarter last year Management provides fiscal 23 revenue guidance of $255 million to $265 million, representing 8% to 12% growth compared to … [Read more…]
Funds Raised Will Support Mental Health Services for Pittsburgh’s LGBTQ+ Community PITTSBURGH–(BUSINESS WIRE)–Persad Center is hosting “2022 Art for Change Event” on Friday, September 9 at Stage AE on the North Shore. The event, Persad’s 35th Annual, is one of the region’s most significant art auctions. Proceeds support Persad Center’s mission of providing mental health … [Read more…]
Dr. Todd Lencz, and others in the Ethics Committee of the International Society of Psychiatric Genetics, publish concerns about polygenic embryo screening in The Lancet Psychiatry MANHASSET, N.Y.–(BUSINESS WIRE)–Genetic testing has been part of the in vitro fertilization (IVF) process for three decades and allows parents to screen embryos for illnesses. Yet, a new technique … [Read more…]
AHF thanks the Los Angeles County Board of Supervisors for proclaiming a state of emergency on monkeypox today; urges the Supervisors to immediately allocate $10M for monkeypox and STDs, and presses County health officials to develop and share their plan of action to handle the outbreak LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) today thanked the … [Read more…]
BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announced today that it will be added to the Russell US Index Series in conjunction with the September 2022 quarterly review, effective after the US market open on Monday, September 19, 2022. Russell indexes are widely … [Read more…]
